Zoetis Inc. [ZTS] Is Currently -3.81 below its 200 Period Moving Avg: What Does This Mean?

Related

Zoetis Inc. [NYSE: ZTS] loss -3.81% or -8.91 points to close at $225.12 with a heavy trading volume of 4654648 shares. The company report on December 23, 2021 that Zoetis to Participate in the 40th Annual J.P. Morgan Healthcare Conference.

Zoetis Inc. (NYSE:ZTS) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 10, 2022. Kristin Peck, Chief Executive Officer, will represent the company and respond to questions from analysts. She is scheduled to present at 1:30 p.m. ET.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Investors and other interested parties will be able to access a live audio webcast of the virtual presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.

It opened the trading session at $234.02, the shares rose to $234.02 and dropped to $222.14, the range by which the price of stock traded the whole day. The daily chart for ZTS points out that the company has recorded 14.04% gains over the past six months. However, it is still -59.2% lower than its most recent low trading price.

If we look at the average trading volume of 1.45M shares, ZTS reached to a volume of 4654648 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Zoetis Inc. [ZTS]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ZTS shares is $246.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ZTS stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Morgan Stanley have made an estimate for Zoetis Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 18, 2021. While these analysts kept the previous recommendation, Morgan Stanley raised their target price to Overweight. The new note on the price target was released on November 18, 2021, representing the official price target for Zoetis Inc. stock. Previously, the target price had yet another raise to $206, while Credit Suisse analysts kept a Outperform rating on ZTS stock.

The Average True Range (ATR) for Zoetis Inc. is set at 5.38, with the Price to Sales ratio for ZTS stock in the period of the last 12 months amounting to 14.05. The Price to Book ratio for the last quarter was 22.81, with the Price to Cash per share for the same quarter was set at 6.88. Price to Free Cash Flow for ZTS in the course of the last twelve months was 79.91 with Quick ratio for the last quarter at 3.30.

Trading performance analysis for ZTS stock

Zoetis Inc. [ZTS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -7.83. With this latest performance, ZTS shares gained by 0.80% in over the last four-week period, additionally plugging by 14.04% over the last 6 months – not to mention a rise of 36.66% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZTS stock in for the last two-week period is set at 40.30, with the RSI for the last a single of trading hit 31.30, and the three-weeks RSI is set at 45.96 for Zoetis Inc. [ZTS]. The present Moving Average for the last 50 days of trading for this stock 225.46, while it was recorded at 239.07 for the last single week of trading, and 197.14 for the last 200 days.

Zoetis Inc. [ZTS]: A deeper dive into fundamental analysis

Zoetis Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.30 and a Current Ratio set at 4.50.

Zoetis Inc. [ZTS]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ZTS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Zoetis Inc. go to 13.57%.

>> 7 Top Picks for the Post-Pandemic Economy <<

An analysis of insider ownership at Zoetis Inc. [ZTS]

There are presently around $100,234 million, or 92.90% of ZTS stock, in the hands of institutional investors. The top three institutional holders of ZTS stocks are: BLACKROCK INC. with ownership of 38,887,998, which is approximately 1.939% of the company’s market cap and around 0.23% of the total institutional ownership; VANGUARD GROUP INC, holding 37,281,849 shares of the stock with an approximate value of $8.73 billion in ZTS stocks shares; and STATE STREET CORP, currently with $4.56 billion in ZTS stock with ownership of nearly 0.606% of the company’s market capitalization.

689 institutional holders increased their position in Zoetis Inc. [NYSE:ZTS] by around 19,998,443 shares. Additionally, 607 investors decreased positions by around 18,812,668 shares, while 238 investors held positions by with 389,483,441 shares. The mentioned changes placed institutional holdings at 428,294,552 shares, according to the latest SEC report filing. ZTS stock had 109 new institutional investments in for a total of 2,195,603 shares, while 67 institutional investors sold positions of 874,253 shares during the same period.